a public good project by the
Synthesis
Company
of California

© 2026

Christian Bjørn Poulsen | doi.page

0 works0 citations0 h-index

Christian Bjørn Poulsen

Roskilde University(DK)University of Copenhagen(DK)Roskilde Sygehus(DK)Zealand University Hospital(DK)University College Copenhagen(DK)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CNS Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Immunodeficiency and Autoimmune Disorders

Most-Cited Works

→ COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)(2021)315 cited
→ First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia(2023)271 cited
→ Histone deacetylase 1, 2, 6 and acetylated histone H4 in B‐ and T‐cell lymphomas(2009)131 cited
→ Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis(2001)74 cited
→ Danish National Lymphoma Registry(2016)70 cited
→ First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial(2024)66 cited

→ Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines(2018)62 cited

→ Brain response to traumatic brain injury in wild‐type and interleukin‐6 knockout mice: a microarray analysis(2004)58 cited

→ Profiling of diffuse large B‐cell lymphoma by immunohistochemistry: identification of prognostic subgroups(2007)58 cited

→ Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial(2022)56 cited